Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Cash & Current Investments (2020 - 2025)

Historic Cash & Current Investments for Neuphoria Therapeutics (NEUP) over the last 6 years, with Q4 2025 value amounting to $22.3 million.

  • Neuphoria Therapeutics' Cash & Current Investments rose 40355.91% to $22.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $22.3 million, marking a year-over-year increase of 40355.91%. This contributed to the annual value of $14.3 million for FY2025, which is N/A changed from last year.
  • As of Q4 2025, Neuphoria Therapeutics' Cash & Current Investments stood at $22.3 million, which was up 40355.91% from $13.7 million recorded in Q3 2025.
  • Neuphoria Therapeutics' 5-year Cash & Current Investments high stood at $29.4 million for Q4 2021, and its period low was $4.4 million during Q4 2024.
  • In the last 5 years, Neuphoria Therapeutics' Cash & Current Investments had a median value of $14.3 million in 2025 and averaged $16.2 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first tumbled by 4926.37% in 2023, then soared by 40355.91% in 2025.
  • Neuphoria Therapeutics' Cash & Current Investments (Quarter) stood at $29.4 million in 2021, then decreased by 18.22% to $24.0 million in 2022, then plummeted by 49.26% to $12.2 million in 2023, then plummeted by 63.78% to $4.4 million in 2024, then surged by 403.56% to $22.3 million in 2025.
  • Its Cash & Current Investments was $22.3 million in Q4 2025, compared to $13.7 million in Q3 2025 and $14.3 million in Q2 2025.